Alirocumab: Revision history

View logs for this page

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

curprev 03:2103:21, 18 July 2021‎ Aysha Aslam talk contribs‎ 69,956 bytes +1‎ No edit summary

curprev 00:0700:07, 22 December 2016‎ Tarek Nafee talk contribs‎ 37,563 bytes +5‎ No edit summary
curprev 00:0700:07, 22 December 2016‎ Tarek Nafee talk contribs‎ 37,558 bytes −68‎ →‎Approved Indications
curprev 00:0600:06, 22 December 2016‎ Tarek Nafee talk contribs‎ 37,626 bytes −41‎ →‎Investigational Indications
curprev 00:0300:03, 22 December 2016‎ Tarek Nafee talk contribs‎ 37,667 bytes +3,041‎ →‎ODYSSEY - CHOICE I Tag: Visual edit

curprev 22:0922:09, 21 December 2016‎ Tarek Nafee talk contribs‎ 34,626 bytes −27‎ →‎Major Trials

curprev 01:2801:28, 20 December 2016‎ Tarek Nafee talk contribs‎ 34,653 bytes +6,327‎ →‎ODYSSEY -ALTERNATIVE Tag: Visual edit

curprev 21:1621:16, 19 December 2016‎ Tarek Nafee talk contribs‎ 28,326 bytes +866‎ →‎Phase III Trials
curprev 15:5615:56, 19 December 2016‎ Tarek Nafee talk contribs‎ 27,460 bytes +32‎ →‎Synopsis

curprev 23:2823:28, 13 December 2016‎ Tarek Nafee talk contribs‎ 14,399 bytes +5‎ →‎Synopsis Tag: Visual edit
curprev 23:2823:28, 13 December 2016‎ Aysha Aslam talk contribs‎ 14,394 bytes +354‎ →‎Synopsis Tag: Visual edit
curprev 20:5620:56, 13 December 2016‎ Tarek Nafee talk contribs‎ 14,040 bytes +740‎ →‎Synopsis Tag: Visual edit

Retrieved from "https://www.wikidoc.org/index.php/Alirocumab"

Cookies help us deliver our services. By using our services, you agree to our use of cookies.